Reoperations after myopic laser in situ keratomileusis.
To evaluate the results after enhancement of myopic laser in situ keratomileusis (LASIK) using the VISX Star excimer laser. The Buzard Eye Institute, Las Vegas, Nevada, USA. In this prospective study, 52 eyes of 40 patients had LASIK enhancement. The existing flap was lifted and the excimer laser treatment reapplied for the residual refractive error. The VISX Star excimer laser was used for the primary LASIK and the enhancement procedure. Retreatments for undercorrection, regression, and overcorrection were performed after 6 weeks and up to 40 weeks after the primary LASIK. Follow-up was 96% at 1 month, 67% at 6 months, and 71% at 12 months. Mean pre-enhancement spherical equivalent was -0.77 diopters (D) +/- 0.94 (SD) and mean uncorrected visual acuity (UCVA), 20/60. One year after the enhancement, mean spherical equivalent was -0.13 +/- 0.33 D, and mean UCVA was 20/25. Refraction remained stable during the 1 year follow-up, with no treatment required. After the enhancement, all patients had a UCVA of 20/40 or better. At 1 year, 3% of patients had lost 1 line of best corrected visual acuity and 32% had gained 1 line. No epithelial ingrowth was noted. Retreatment for LASIK beginning 6 weeks after the initial procedure proved to be effective with minimal complications and good results. The technique to raise and reposition the flap appeared safe, and complications were few.